SavedAdd your journal

Journals / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 2

Primary Signet-ring Cell Carcinoma of Colorectal Origin: A Poor Prognostic Entity

Abdilkerim OYMAN
Mustafa BAŞAK
Pages
213–217
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Median overall survival (mOS)was 28.5 months.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this retrospective study, we aimed to evaluate the clinicopathologic characteristics and survival out comes of colorectal cancer patients with signet-ring cell component.
📊
Key Findings & Data:Methods: 2673 patients diagnosed with colorectal cancer who presented to two different institutions from 2004 to2019 were investigated.
💡
Conclusion & Impact:Median overall survival (mOS)was 28.5 months.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this retrospective study, we aimed to evaluate the clinicopathologic characteristics and survival out comes of colorectal cancer patients with signet-ring cell component. Methods: 2673 patients diagnosed with colorectal cancer who presented to two different institutions from 2004 to2019 were investigated. A total of 75 patients with primary signet-ring cell component were included in the study. Results: A total of 75 patients with primary signet-ring cell component were included in the study. 49 (65.3%) werepatients with signet-ring cell components more than 50%, 26 (34.7%) were patients with signet-ring cell componentsless than 50%. At the time of diagnosis, 8 (10.7%) patients had Stage 1-2, 53 (70.7%) patients had Stage 3 and 14 (18.6%)patients had Stage 4 disease. The mean follow-up period of the patients was 54 months. Median overall survival (mOS)was 28.5 months. The mOS of patients who developed metastasis at the time of diagnosis was 9.3 months and mOS ofpatients without metastasis was 36.5 months. Conclusion: It was observed that primary signet-ring cell carcinomas were mostly seen in males and localized in leftcolon and had a worse prognosis than classical adenocarcinomas.

🔖

Cite This Article

OYMAN, A., BAŞAK, M. (2022). Primary Signet-ring Cell Carcinoma of Colorectal Origin: A Poor Prognostic Entity. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 2, 213–217. https://ajindex.com/articles/508587

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29
  2. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Geneva: WHO, International Agency for Research on Cancer; 2010
  3. Nitsche U, Zimmermann A, Späth C, Müller T, Maak M, Schuster T, et al. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg 2013;258:775–82; discussion 782–3
  4. LAUFMAN H, SAPHIR O. Primary linitis plastica type of carcinoma of the colon. AMA Arch Surg 1951;62:79–91
  5. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. Geneva: WHO, IARC; 2000
  6. Chen JS, Hsieh PS, Chiang JM, Yeh CY, Tsai WS, Tang R, et al. Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon. Chang Gung Med J 2010;33:51– 7
  7. Casavilca Zambrano S, Sanchez Lihon J, Zavaleta A. colon and rectum signet-ring cell carcinoma in the national institute of neoplastic diseases. Rev Gastroenterol Peru 2004;24:234–37
  8. Ibrahim NK, Abdul-Karim FW. Colorectal adenocarcinoma in young Lebanese adults: the American University of Beirut-Int Surg Medical Center experience with 32 patients. Cancer 1986;58:816–20
  9. Psathakis D, Schiedeck TH, Krug F, Oevermann E, Kujath P, Bruch HP. Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade, and stage. Dis Colon Rectum 1999;42:1618–25
  10. Lang K, Korn JR, Lee DW, Lines LM, Earle CC, Menzin J. Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer 2009;9:227
  11. Gopalan V, Smith RA, Ho YH, Lam AK. Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology. Int J Colorectal Dis 2011;26:127–33
  12. Tung SY, Wu CS, Chen PC. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study. Am J Gastroenterol 1996;91:2195–9
  13. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 2005;48:1161–8
  14. Lee WS, Chun HK, Lee WY, Yun SH, ChoY B, Yun HR, et al. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. AmJ Surg 2007;194:S294–8
  15. Hugen N, Verhoeven RH, Lemmens VE, van Aart CJ, Elferink MA, Radema SA, et al. Col